An engineered R-type pyocin is a highly specific and sensitive bactericidal agent for the food-borne pathogen Escherichia coli O157:H7

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 7, 2009, Pages 3074-3080

  Scholl, Dean ^a   Cooley, Mike ^b   Williams, Steve R ^a   Gebhart, Dana ^a   Martin, David ^a   Bates, Anna ^b   Mandrell, Robert ^b  

^a AvidBiotics Corporation   (United States)

^b WESTERN REGIONAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; HYBRID PROTEIN; PYOCIN; SHIGA TOXIN;

ARTICLE; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BACTERIOPHAGE; BEEF; CONTROLLED STUDY; ESCHERICHIA COLI O157; FOOD CONTAMINATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN LIPID INTERACTION; PSEUDOMONAS AERUGINOSA; SENSITIVITY AND SPECIFICITY;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; ESCHERICHIA COLI O157; FOOD MICROBIOLOGY; MODELS, BIOLOGICAL; PYOCINS; SHIGA TOXIN;

EID: 67650072870     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01660-08     Document Type: Article

References (33)

1. Ahn, C. K., E. Klein, and P. I. Tarr. 2008. Isolation of patients acutely infected with Escherichia coli O157:H7: low tech, highly effective prevention of hemolytic uremic syndrome. Clin. Infect. Dis. 46:1197-1199.
2. Cooley, M., D. Carychao, L. Crawford-Miksza, M. T. Jay, C. Myers, C. Rose, C. Keys, J. Farrar, and R. E. Mandrell. 2008. Incidence and tracking of E. coli O157:H7 in a major produce production region in California. PLoS One 2:e1159.
3. BAD promoter. J. Bacteriol. 177:4121-4130.
4. Haas, H., T. Sacks, and N. Saltz. 1974. Protective effect of pyocin against lethal Pseudomonas aeruginosa infections in mice. J. Infect. Dis. 129:470-472.
5. Ho, T. D., and M. K. Waldor. 2007. Enterohemorrhagic Escherichia coli O157:H7 gal mutants are sensitive to bacteriophage P1 and defective in intestinal colonization. Infect. Immun. 75:1661-1666.
6. Ishii, S., Y. Nishi, and F. Egami. 1965. The fine structure of a pyocin. J. Mol. Biol. 13:428-431.
7. Ito, S., M. Kageyama, and F. Egami. 1970. Isolation and characterization of pyocins from several strains of Pseudomonas aeruginosa. J. Gen. Appl. Microbiol. 16:205-214.
8. Jiang, W., J. Chang, J. Jakana, P. Weigele, J. King, and W. Chiu. 2006. Structure of epsilon15 bacteriophage reveals genome organization and DNA packaging/injection apparatus. Nature 439:612-616.
9. Kageyama, M. 1964. Studies of a pyocin. I. Physical and chemical properties. J. Biochem. 55:49-53.
10. Kageyama, M., K. Ikeda, and F. Egami. 1964. Studies of a pyocin. III. Biological properties of the pyocin. J. Biochem. 55:59-64.
11. King, M. R., R. P. Vimr, S. M. Steenbergen, L. Spanjaard, G. Plunkett III, F. R. Blattner, and E. R. Vimr. 2007. Escherichia coli K1-specific bacteriophage CUS-3 distribution and function in phase-variable capsular polysialic acid O acetylation. J. Bacteriol. 189:6447-6456.
12. Kropinski, A. M., I. V. Kovalyova, S. J. Billington, A. N. Patrick, B. D. Butts, J. A. Guichard, T. J. Pitcher, C. C. Guthrie, A. D. Sydlaske, L. M. Barnhill, K. A. Havens, K. R. Day, D. R. Falk, and M. R. McConnell. 2007. The genome of epsilon15, a serotype-converting, group E1 Salmonella enterica-specific bacteriophage. Virology 369:234-244.
13. Long, G. S., J. M. Bryant, P. W. Taylor, and J. P. Luzio. 1995. Complete nucleotide sequence of the gene encoding bacteriophage E endosialidase: implications for K1E endosialidase structure and function. Biochem. J. 309: 543-550.
14. Machida, Y., K. Miyake, K. Hattori, S. Yamamoto, M. Kawase, and S. Iijima. 2000. Structure and function of a novel coliphage-associated sialidase. FEMS Microbiol. Lett. 182:333-337.
15. Matsui, H., Y. Sano, H. Ishihara, and T. Shinomiya. 1993. Regulation of pyocin genes in Pseudomonas aeruginosa by positive (prtN) and negative (prtR) regulatory genes. J. Bacteriol. 175:1257-1263.
16. Merrikin, D. J., and C. S. Terry. 1972. Use of pyocin 78-C2 in the treatment of Pseudomonas aeruginosa infection in mice. Appl. Microbiol. 23:164-165.
17. Michel-Briand, Y., and C. Baysse. 2002. The pyocins of Pseudomonas aeruginosa. Biochimie 84:499-510.
18. Nakayama, K., K. Takashima, H. Ishihara, T. Shinomiya, M. Kageyama, S. Kanaya, M. Ohnishi, T. Murata, H. Mori, and T. Hayashi. 2000. The R-type pyocin of Pseudomonas aeruginosa is related to P2 phage, and the F-type is related to lambda phage. Mol. Microbiol. 38:213-231.
19. Rangel, J. M., P. H. Sparling, C. Crowe, P. M. Griffin, and D. L. Swerdlow. 2005. Epidemiology of E. coli O157:H7 outbreaks, United States, 1982-2002. Emerg. Infect. Dis. 11:603-609.
20. Scholl, D., and C. Merril. 2005. The genome sequence of bacteriophage K1F, a T7-like phage that has acquired the ability to infect K1 strains of E. coli. J. Bacteriol. 187:8499-8503.
21. Scholl, D., and C. Merril. 2005. Polysaccharide-degrading phages, p. 400-414. In Phages: their role in bacterial pathogenesis and biotechnology. ASM Press, Washington, DC.
22. Scholl, D., and D. W. Martin, Jr. 2008. Antibacterial efficacy of R-type pyocins towards Pseudomonas aeruginosa in a mouse peritonitis model. Antimicrob. Agents Chemother. 52:1647-1652.
23. Seckler, R. 1998. Folding and function of repetitive structure in the homotrimeric phage P22 tailspike protein. J. Struct. Biol. 122:216-222.
24. Shimizu, Y., T. Kamazaki, and S. I. Ishii. 1982. Specific cleavage at fibers of a bacteriophage-tail-like bacteriocin, pyocin R1 by successive treatment with organomercurial compounds and trypsin. J. Virol. 44:692-695.
25. Shinomiya, T., S. Shiga, and M. Kageyama. 1983. Genetic determinant of pyocin R2 in Pseudomonas aeruginosa PAO. I. Localization of the pyocin R2 gene cluster between the trpCD and trpE genes. Mol. Gen. Genet. 189:375-381.
26. Sivapalasingam, S., C. R. Friedman., L. Cohen, and R. V. Tauxe. 2004. Fresh produce: a rowing cause of outbreaks of foodborne illness in the United States, 1973 through 1997. J. Food Prot. 67:2342-2353.
27. Steven, A. C., B. L. Trus, J. V. Maizel, M. Unser, D. A. D. Parry. J. S. Wall, J. F. Hainfield, and W. F. Studier. 1988. Molecular substructure of a viral receptor-recognition protein. J. Mol. Biol. 200:351-365.
28. Strauch, E., H. Kaspar, C. Schaudinn, P. Dersch, K. Madela, C. Gewinner, S. Hertwig, J. O. Wecke, and B. Appel. 2001. Characterization of enterocoliticin, a phage tail-like bacteriocin, and its effect on pathogenic Yersinia enterocolitica strains. Appl. Environ. Microbiol. 67:5634-5642.
29. Uratani, Y., and T. Hoshino. 1984. Pyocin R1 inhibits active transport in Pseudomonas aeruginosa and depolarizes membrane potential. J. Bacteriol. 157:632-636.
30. Waddell, T. E., and C. Poppe. 2000. Construction of mini-Tn10luxABcam/ Ptac-ATS and its use for developing a bacteriophage that transduces bioluminescence to Escherichia coli O157:H7. FEMS Microbiol. Lett. 182:285-289.
31. Walter, M., C. Fiedler, R. Grassl, M. Biebl, R. Rachel, X. L. Hermo-Parrado, A. L. Llamas-Saiz, R. Seckler, S. Miller, and M. J. van Raaij. 2008. Structure of the receptor-binding protein of bacteriophage det7: a podoviral tail spike in a myovirus. J. Virol. 82:2265-2273.
32. Williams, S., D. Gebhart, D. W. Martin, and D. Scholl. 2008. Re-targeting R-type pyocins to generate novel bactericidal protein complexes. Appl. Environ. Microbiol. 74:3868-3876.
33. Wong, C. S., S. Jelacic, R. L. Habeeb, S. L. Watkins, and P. I. Tarr. 2000. The risk of hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N. Engl. J. Med. 342:1930-1936.